IN8bio, Inc. - Common Stock (NQ:INAB)

1.420 +0.020 (+1.43%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IN8bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

INAB Stock Earnings: IN8bio Misses EPS for Q2 2024 ↗

August 09, 2024

INAB stock results show that IN8bio missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 14, 2024

Via Benzinga

INAB Stock Earnings: IN8bio Misses EPS for Q1 2024 ↗

May 09, 2024

INAB stock results show that IN8bio missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

INAB Stock Earnings: IN8bio Misses EPS for Q4 2023 ↗

March 14, 2024

INAB stock results show that IN8bio missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Gold Gains 1%; US Consumer Sentiment Falls In June ↗

June 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 07, 2024

Via Benzinga

IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

May 09, 2024

From IN8bio, Inc

Via GlobeNewswire

IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma

April 30, 2024

From IN8bio, Inc

Via GlobeNewswire

IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

April 24, 2024

From IN8bio, Inc

Via GlobeNewswire

IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference

April 16, 2024

From IN8bio, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 12, 2024

Via Benzinga

Kill Leukemia Cells While Preserving Healthy Tissues: Nano-Cap Cancer Focused Firm IN8bio's Preclinical Candidate Shows Potential ↗

April 10, 2024

IN8bio's nsCAR platform, INB-300. Presented at AACR 2024, new preclinical data highlights its superior selectivity in targeting leukemia cells while sparing healthy tissue. Experience a potential wider...

Via Benzinga

Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket ↗

April 10, 2024

Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for its second quarter.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 10, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

April 10, 2024

Pre-market stock movers are worth diving into on Wednesday morning to get ready for all of the hottest news moving shares today!

Via InvestorPlace

IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024

April 09, 2024

From IN8bio, Inc

Via GlobeNewswire

IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights

March 14, 2024

From IN8bio, Inc

Via GlobeNewswire

IN8bio to Present at Upcoming Investor Conferences

February 26, 2024

From IN8bio, Inc.

Via Business Wire

IN8bio’s Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data

January 23, 2024

--News Direct--

Via News Direct

IN8bio's Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data ↗

January 22, 2024

IN8bio (NASDAQ: INAB) is a biotechnology company that specializes in developing novel therapies based on gamma-delta T cells. Its innovative technology focuses on harnessing the potential of these...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 18, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 15, 2023

Via Benzinga

Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

December 13, 2023

Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700...

Via Benzinga

Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket ↗

December 13, 2023

Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. ReShape...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

December 13, 2023

Pre-market stock movers are a hot topic on Wednesday and we're starting the day with a breakdown of the biggest ones worth watching!

Via InvestorPlace

Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 12, 2023

Shares of Johnson Controls International plc (NYSE: JCI) moved lower during Tuesday’s session following weak quarterly results.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 12, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 12, 2023

Via Benzinga

Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket ↗

December 12, 2023

Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.